Clinical trial
A Prospective Trial Of Empiric Quinidine Therapy For Asymptomatic Brugada Syndrome.
NCT00789165 is registered in ClinicalTrials.gov with International Registry of Asymptomatic Brugada Syndrome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Trial Of Empiric Quinidine Therapy For Asymptomatic Brugada Syndrome.
- Lead sponsor
- International Registry of Asymptomatic Brugada Syndrome
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- December 31, 2009
- Completion date
- December 31, 2020
- Enrollment
- 0 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia